Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Low-risk prostate cancer can and should often be managed with active surveillance and selective delayed intervention.

Literature DB >> 18043601

Low-risk prostate cancer can and should often be managed with active surveillance and selective delayed intervention.

Laurence Klotz¹.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2007 PMID： 18043601 DOI： 10.1038/ncpuro0993

Source DB: PubMed Journal: Nat Clin Pract Urol ISSN： 1743-4270

Keyword Cloud
Cited

× No keyword cloud information.

10 in total

1. Impact of immediate TRUS rebiopsy in a patient cohort considering active surveillance for favorable risk prostate cancer.

Authors: Andre C King; Andrew Livermore; Timo A J Laurila; Wei Huang; David F Jarrard
Journal: Urol Oncol Date: 2011-08-03 Impact factor: 3.498

Review 2. Active surveillance in prostate cancer: the need to standardize.

Authors: Xavier Filella; Juan Alcover; Rafael Molina
Journal: Tumour Biol Date: 2011-05-28

3. Algorithms, nomograms and the detection of indolent prostate cancer.

Authors: Monique J Roobol
Journal: World J Urol Date: 2008-06-07 Impact factor: 4.226

4. Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention.

Authors: Dean Ornish; Mark Jesus M Magbanua; Gerdi Weidner; Vivian Weinberg; Colleen Kemp; Christopher Green; Michael D Mattie; Ruth Marlin; Jeff Simko; Katsuto Shinohara; Christopher M Haqq; Peter R Carroll
Journal: Proc Natl Acad Sci U S A Date: 2008-06-16 Impact factor: 11.205

5. Gene expression and biological pathways in tissue of men with prostate cancer in a randomized clinical trial of lycopene and fish oil supplementation.

Authors: Mark Jesus M Magbanua; Ritu Roy; Eduardo V Sosa; Vivian Weinberg; Scott Federman; Michael D Mattie; Millie Hughes-Fulford; Jeff Simko; Katsuto Shinohara; Christopher M Haqq; Peter R Carroll; June M Chan
Journal: PLoS One Date: 2011-09-01 Impact factor: 3.240

Low-risk prostate cancer can and should often be managed with active surveillance and selective delayed intervention.

1. Impact of immediate TRUS rebiopsy in a patient cohort considering active surveillance for favorable risk prostate cancer.

Review 2. Active surveillance in prostate cancer: the need to standardize.

3. Algorithms, nomograms and the detection of indolent prostate cancer.

4. Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention.

5. Gene expression and biological pathways in tissue of men with prostate cancer in a randomized clinical trial of lycopene and fish oil supplementation.

6. Prognostic factors for failure after prostatectomy.

Review 7. Prostate Cancer Detection and Prognosis: From Prostate Specific Antigen (PSA) to Exosomal Biomarkers.

Review 8. Emerging biomarkers in the diagnosis of prostate cancer.

Review 9. Detection and Prognosis of Prostate Cancer Using Blood-Based Biomarkers.

Review 10. Clinical utility of current biomarkers for prostate cancer detection.